17-45816520-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_004382.5(CRHR1):​c.179C>T​(p.Ala60Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00795 in 1,614,102 control chromosomes in the GnomAD database, including 80 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0065 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0081 ( 73 hom. )

Consequence

CRHR1
NM_004382.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.37

Publications

19 publications found
Variant links:
Genes affected
CRHR1 (HGNC:2357): (corticotropin releasing hormone receptor 1) This gene encodes a G-protein coupled receptor that binds neuropeptides of the corticotropin releasing hormone family that are major regulators of the hypothalamic-pituitary-adrenal pathway. The encoded protein is essential for the activation of signal transduction pathways that regulate diverse physiological processes including stress, reproduction, immune response and obesity. Alternative splicing results in multiple transcript variants. Naturally-occurring readthrough transcription between this gene and upstream GeneID:147081 results in transcripts that encode isoforms that share similarity with the products of this gene. [provided by RefSeq, Aug 2016]
LINC02210-CRHR1 (HGNC:51483): (LINC02210-CRHR1 readthrough) This locus represents naturally occurring readthrough transcription between neighboring genes CRHR1-IT1, CRHR1 intronic transcript 1 (Gene ID: 147081) and CRHR1, corticotropin releasing hormone receptor 1 (Gene ID: 1394) on chromosome 17. The readthrough transcript encodes a protein that shares sequence identity with the product of the CRHR1 gene. [provided by RefSeq, Dec 2016]
MAPT-AS1 (HGNC:43738): (MAPT antisense RNA 1) Implicated in Parkinson's disease. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012295485).
BP6
Variant 17-45816520-C-T is Benign according to our data. Variant chr17-45816520-C-T is described in ClinVar as [Benign]. Clinvar id is 771768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 993 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRHR1NM_004382.5 linkc.179C>T p.Ala60Val missense_variant Exon 3 of 13 ENST00000314537.10 NP_004373.2 P34998-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRHR1ENST00000314537.10 linkc.179C>T p.Ala60Val missense_variant Exon 3 of 13 1 NM_004382.5 ENSP00000326060.6 P34998-2
LINC02210-CRHR1ENST00000634540.1 linkc.-347C>T 5_prime_UTR_variant Exon 5 of 15 2 ENSP00000488912.1

Frequencies

GnomAD3 genomes
AF:
0.00653
AC:
993
AN:
152176
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00210
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00621
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0116
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00644
AC:
1603
AN:
248836
AF XY:
0.00625
show subpopulations
Gnomad AFR exome
AF:
0.00169
Gnomad AMR exome
AF:
0.00128
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00576
Gnomad NFE exome
AF:
0.0117
Gnomad OTH exome
AF:
0.00529
GnomAD4 exome
AF:
0.00810
AC:
11841
AN:
1461808
Hom.:
73
Cov.:
32
AF XY:
0.00805
AC XY:
5853
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.00111
AC:
37
AN:
33480
American (AMR)
AF:
0.00107
AC:
48
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00176
AC:
46
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00119
AC:
103
AN:
86252
European-Finnish (FIN)
AF:
0.00650
AC:
347
AN:
53374
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00976
AC:
10857
AN:
1111984
Other (OTH)
AF:
0.00661
AC:
399
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
689
1378
2066
2755
3444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00652
AC:
993
AN:
152294
Hom.:
7
Cov.:
33
AF XY:
0.00563
AC XY:
419
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00209
AC:
87
AN:
41550
American (AMR)
AF:
0.00157
AC:
24
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4824
European-Finnish (FIN)
AF:
0.00621
AC:
66
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0116
AC:
792
AN:
68018
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00902
Hom.:
12
Bravo
AF:
0.00549
TwinsUK
AF:
0.00917
AC:
34
ALSPAC
AF:
0.0101
AC:
39
ESP6500AA
AF:
0.00182
AC:
7
ESP6500EA
AF:
0.0108
AC:
89
ExAC
AF:
0.00716
AC:
865
EpiCase
AF:
0.00851
EpiControl
AF:
0.00919

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
21
DANN
Benign
0.96
DEOGEN2
Benign
0.30
.;.;.;T
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.21
FATHMM_MKL
Benign
0.71
D
LIST_S2
Uncertain
0.88
D;D;D;D
MetaRNN
Benign
0.012
T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.7
.;L;L;L
PhyloP100
1.4
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-2.2
.;N;.;N
REVEL
Benign
0.12
Sift
Benign
0.051
.;T;.;T
Sift4G
Uncertain
0.058
T;T;T;D
Polyphen
0.12, 0.24, 0.29
.;B;B;B
Vest4
0.15
MVP
0.57
MPC
0.64
ClinPred
0.012
T
GERP RS
4.1
Varity_R
0.55
gMVP
0.81
Mutation Taster
=283/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16940655; hg19: chr17-43893886; API